These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 26561948

  • 1. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo.
    Gomez-Gutierrez JG, Nitz J, Sharma R, Wechman SL, Riedinger E, Martinez-Jaramillo E, Sam Zhou H, McMasters KM.
    Virology; 2016 Jan; 487():249-59. PubMed ID: 26561948
    [Abstract] [Full Text] [Related]

  • 2. Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.
    Garza-Morales R, Yaddanapudi K, Perez-Hernandez R, Riedinger E, McMasters KM, Shirwan H, Yolcu E, Montes de Oca-Luna R, Gomez-Gutierrez JG.
    Cancer Biol Ther; 2018 Mar 04; 19(3):188-197. PubMed ID: 29252087
    [Abstract] [Full Text] [Related]

  • 3. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
    Jiang G, Sun C, Li RH, Wei ZP, Zheng JN, Liu YQ.
    J Cancer Res Clin Oncol; 2015 Jan 04; 141(1):75-85. PubMed ID: 25103017
    [Abstract] [Full Text] [Related]

  • 4. Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients.
    Liikanen I, Ahtiainen L, Hirvinen ML, Bramante S, Cerullo V, Nokisalmi P, Hemminki O, Diaconu I, Pesonen S, Koski A, Kangasniemi L, Pesonen SK, Oksanen M, Laasonen L, Partanen K, Joensuu T, Zhao F, Kanerva A, Hemminki A.
    Mol Ther; 2013 Jun 04; 21(6):1212-23. PubMed ID: 23546299
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect.
    Kim J, Kim PH, Yoo JY, Yoon AR, Choi HJ, Seong J, Kim IW, Kim JH, Yun CO.
    Gene Ther; 2009 Sep 04; 16(9):1111-21. PubMed ID: 19494843
    [Abstract] [Full Text] [Related]

  • 8. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
    Liu TC, Wang Y, Hallden G, Brooks G, Francis J, Lemoine NR, Kirn D.
    Gene Ther; 2005 Sep 04; 12(17):1333-46. PubMed ID: 15920462
    [Abstract] [Full Text] [Related]

  • 9. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.
    Mantwill K, Naumann U, Seznec J, Girbinger V, Lage H, Surowiak P, Beier D, Mittelbronn M, Schlegel J, Holm PS.
    J Transl Med; 2013 Sep 18; 11():216. PubMed ID: 24044901
    [Abstract] [Full Text] [Related]

  • 10. HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategy.
    Xu HN, Huang WD, Cai Y, Ding M, Gu JF, Wei N, Sun LY, Cao X, Li HG, Zhang KJ, Liu XR, Liu XY.
    Mol Cancer; 2011 Nov 01; 10():133. PubMed ID: 22040050
    [Abstract] [Full Text] [Related]

  • 11. Markedly enhanced cytolysis by E1B-19kD-deleted oncolytic adenovirus in combination with cisplatin.
    Yoon AR, Kim JH, Lee YS, Kim H, Yoo JY, Sohn JH, Park BW, Yun CO.
    Hum Gene Ther; 2006 Apr 01; 17(4):379-90. PubMed ID: 16610926
    [Abstract] [Full Text] [Related]

  • 12. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer.
    Zhang Z, Huang Y, Newman K, Gu J, Zhang X, Wu H, Zhao M, Xianyu Z, Liu X.
    Clin Cancer Res; 2009 Aug 15; 15(16):5154-60. PubMed ID: 19671855
    [Abstract] [Full Text] [Related]

  • 13. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
    Zhang Y, Gu J, Zhao L, He L, Qian W, Wang J, Wang Y, Qian Q, Qian C, Wu J, Liu XY.
    Cancer Res; 2006 Apr 15; 66(8):4291-8. PubMed ID: 16618754
    [Abstract] [Full Text] [Related]

  • 14. A novel Golgi protein (GOLPH2)-regulated oncolytic adenovirus exhibits potent antitumor efficacy in hepatocellular carcinoma.
    Wang Y, Liu T, Huang P, Zhao H, Zhang R, Ma B, Chen K, Huang F, Zhou X, Cui C, Liu X.
    Oncotarget; 2015 May 30; 6(15):13564-78. PubMed ID: 25980438
    [Abstract] [Full Text] [Related]

  • 15. The antitumor effects of oncolytic adenovirus H101 against lung cancer.
    Lei J, Li QH, Yang JL, Liu F, Wang L, Xu WM, Zhao WX.
    Int J Oncol; 2015 Aug 30; 47(2):555-62. PubMed ID: 26081001
    [Abstract] [Full Text] [Related]

  • 16. Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.
    Lei W, Liu HB, Wang SB, Zhou XM, Zheng SD, Guo KN, Ma BY, Xia YL, Tan WS, Liu XY, Wang YG.
    Acta Pharmacol Sin; 2013 Apr 30; 34(4):531-40. PubMed ID: 23503473
    [Abstract] [Full Text] [Related]

  • 17. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
    Wakayama M, Abei M, Kawashima R, Seo E, Fukuda K, Ugai H, Murata T, Tanaka N, Hyodo I, Hamada H, Yokoyama KK.
    Clin Cancer Res; 2007 May 15; 13(10):3043-50. PubMed ID: 17505007
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of tumor suppressor TSLC1 by a survivin-regulated oncolytic adenovirus significantly inhibits hepatocellular carcinoma growth.
    He G, Lei W, Wang S, Xiao R, Guo K, Xia Y, Zhou X, Zhang K, Liu X, Wang Y.
    J Cancer Res Clin Oncol; 2012 Apr 15; 138(4):657-70. PubMed ID: 22237452
    [Abstract] [Full Text] [Related]

  • 19. Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells.
    Yokoyama T, Iwado E, Kondo Y, Aoki H, Hayashi Y, Georgescu MM, Sawaya R, Hess KR, Mills GB, Kawamura H, Hashimoto Y, Urata Y, Fujiwara T, Kondo S.
    Gene Ther; 2008 Sep 15; 15(17):1233-9. PubMed ID: 18580968
    [Abstract] [Full Text] [Related]

  • 20. Viral genome DNA/lipoplexes elicit in situ oncolytic viral replication and potent antitumor efficacy via systemic delivery.
    Kwon OJ, Kang E, Kim S, Yun CO.
    J Control Release; 2011 Oct 30; 155(2):317-25. PubMed ID: 21699929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.